Harvard Bioscience, Inc. (HBIO)

USD 2.03

(-6.45%)

Operating Expenses Summary of Harvard Bioscience, Inc.

  • Harvard Bioscience, Inc.'s latest annual operating expenses in 2023 was 58.58 Million USD , down -13.83% from previous year.
  • Harvard Bioscience, Inc.'s latest quarterly operating expenses in 2024 Q2 was 13.7 Million USD , down -7.08% from previous quarter.
  • Harvard Bioscience, Inc. reported a annual operating expenses of 67.98 Million USD in annual operating expenses 2022, up 3.66% from previous year.
  • Harvard Bioscience, Inc. reported a annual operating expenses of 65.58 Million USD in annual operating expenses 2021, up 13.43% from previous year.
  • Harvard Bioscience, Inc. reported a quarterly operating expenses of 13.7 Million USD for 2024 Q2, down -7.08% from previous quarter.
  • Harvard Bioscience, Inc. reported a quarterly operating expenses of 15.66 Million USD for 2023 Q3, down -1.37% from previous quarter.

Annual Operating Expenses Chart of Harvard Bioscience, Inc. (2023 - 1998)

Historical Annual Operating Expenses of Harvard Bioscience, Inc. (2023 - 1998)

Year Operating Expenses Operating Expenses Growth
2023 58.58 Million USD -13.83%
2022 67.98 Million USD 3.66%
2021 65.58 Million USD 13.43%
2020 57.82 Million USD -7.47%
2019 62.48 Million USD 0.46%
2018 62.19 Million USD 30.4%
2017 47.69 Million USD -3.74%
2016 49.55 Million USD -0.2%
2015 49.64 Million USD 16.79%
2014 42.5 Million USD -3.41%
2013 44 Million USD -10.08%
2012 48.94 Million USD 11.95%
2011 43.71 Million USD 6.47%
2010 41.06 Million USD 24.01%
2009 33.11 Million USD 3.09%
2008 32.11 Million USD 4.57%
2007 30.71 Million USD 4.48%
2006 29.39 Million USD 15.96%
2005 25.35 Million USD -39.2%
2004 41.69 Million USD 16.64%
2003 35.74 Million USD 45.42%
2002 24.58 Million USD 26.43%
2001 19.44 Million USD -24.65%
2000 25.8 Million USD 109.38%
1999 12.32 Million USD 180.64%
1998 4.39 Million USD 0.0%

Peer Operating Expenses Comparison of Harvard Bioscience, Inc.

Name Operating Expenses Operating Expenses Difference
Akoya Biosciences, Inc. 104.27 Million USD 43.818%
AngioDynamics, Inc. 252.41 Million USD 76.792%
AtriCure, Inc. 327.05 Million USD 82.088%
Avinger, Inc. 18.63 Million USD -214.309%
Azenta, Inc. 336.26 Million USD 82.579%
BioLife Solutions, Inc. 117.57 Million USD 50.176%
The Cooper Companies, Inc. 1.82 Billion USD 96.79%
Daxor Corporation 1.28 Million USD -4474.8%
Ekso Bionics Holdings, Inc. 24.19 Million USD -142.16%
Femasys Inc. 15.2 Million USD -285.393%
GlucoTrack, Inc. 7.1 Million USD -724.62%
Hologic, Inc. 1.34 Billion USD 95.645%
ICU Medical, Inc. 717.04 Million USD 91.83%
Intuitive Surgical, Inc. 2.96 Billion USD 98.023%
KORU Medical Systems, Inc. 26.1 Million USD -124.381%
LeMaitre Vascular, Inc. 90.33 Million USD 35.153%
Innovative Eyewear, Inc. -119.32 Thousand USD 49192.006%
Innovative Eyewear, Inc. -119.32 Thousand USD 49192.006%
Masimo Corporation 867 Million USD 93.243%
Microbot Medical Inc. 9.85 Million USD -494.429%
Meihua International Medical Technologies Co., Ltd. 18.42 Million USD -218.028%
Merit Medical Systems, Inc. 459.92 Million USD 87.263%
Nephros, Inc. 9.78 Million USD -498.743%
NovoCure Limited 613.92 Million USD 90.458%
NEXGEL, Inc. 4.09 Million USD -1330.2%
NEXGEL, Inc. 4.09 Million USD -1330.2%
Singular Genomics Systems, Inc. 102.24 Million USD 42.704%
OraSure Technologies, Inc. 125.34 Million USD 53.263%
Pro-Dex, Inc. 7.37 Million USD -693.996%
Pulse Biosciences, Inc. 43.57 Million USD -34.44%
Predictive Oncology Inc. 15.22 Million USD -284.654%
Precision Optics Corporation, Inc. 8.52 Million USD -587.4%
QuidelOrtho Corporation 1.35 Billion USD 95.678%
Repligen Corporation 261.12 Million USD 77.566%
Sanara MedTech Inc. 61.12 Million USD 4.165%
STAAR Surgical Company 224.55 Million USD 73.912%
Sharps Technology, Inc. 10.12 Million USD -478.484%
Utah Medical Products, Inc. 13.26 Million USD -341.754%
DENTSPLY SIRONA Inc. 1.79 Billion USD 96.735%
Jin Medical International Ltd. 3.91 Million USD -1395.339%